Krishna Institute of Medical Sciences: Change in Director(s) of the company
Krishna Institute of Medical Sciences (KIMS) filed a disclosure titled "Change in Director(s) of the company". The company is valued at about ₹31,104 crore.
What happened
Krishna Institute of Medical Sciences (KIMS) filed a disclosure with the exchanges on 4 November 2026 at 08:24 PM titled "Change in Director(s) of the company".
Company snapshot
Krishna Institute of Medical Sciences is a mid-cap company in the Healthcare sector, with a market value of about ₹31,104 crore.
The stock last traded at ₹740.6, against a 52-week range of ₹575.8–₹858 (13.7% below the high).
Before this filing the shares had moved −0.8% over the month and −8.9% over three months. Average daily turnover over the last 20 sessions was about ₹28.54 crore.
Promoters held 32.50% at the end of Q1 FY27; 10.26% of promoter shares were pledged. Foreign institutions owned 14.74% and domestic institutions 34.43%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 872 | 78.6 | 1.96 |
| Q2 FY26 | 961 | 67.1 | 1.67 |
| Q3 FY26 | 998 | 53.4 | 1.33 |
| Q4 FY26 | 1,075 | 42.5 | 1.06 |
| Q1 FY27 | 1,180 | 41.5 | 1.04 |
What history shows
BCEIE has no earlier management change filing from this company on record since May 2026.
Across 123 similar disclosures by other Healthcare companies, shares moved +1.1% on average the next day and +1.8% over five days; 50% of them rose the next day.
Market-wide, 4,282 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 4 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Krishna Institute of Medical Sciences acquires 51% stake in Sarvottam for ₹79.50 crore
- KIMS Legal Update: Chennai Hospital Project Continues Amid Ongoing Land Dispute
- Stocks in Focus: NCC, Krishna Institute, Affle 3i, and Others
- KIMS Plans 51% Sarvottam Stake in ₹80 Crore Healthcare Deal
- Krishna Institute of Medical Sciences acquires 5.82% stake in Ushahkal Hospital
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.